Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 59% ± 17% | |
brain | 18 studies | 40% ± 12% | |
peripheral blood | 17 studies | 35% ± 11% | |
intestine | 14 studies | 50% ± 25% | |
kidney | 9 studies | 58% ± 16% | |
eye | 9 studies | 46% ± 21% | |
bone marrow | 6 studies | 35% ± 17% | |
liver | 6 studies | 53% ± 17% | |
pancreas | 5 studies | 59% ± 24% | |
uterus | 5 studies | 71% ± 18% | |
lymph node | 5 studies | 53% ± 21% | |
placenta | 4 studies | 58% ± 24% | |
esophagus | 4 studies | 57% ± 30% | |
prostate | 4 studies | 39% ± 8% | |
breast | 4 studies | 71% ± 11% | |
heart | 3 studies | 35% ± 15% | |
adipose | 3 studies | 23% ± 8% | |
adrenal gland | 3 studies | 53% ± 13% | |
skin | 3 studies | 61% ± 25% | |
thymus | 3 studies | 70% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 11163.85 | 1445 / 1445 | 100% | 207.12 | 183 / 183 |
ovary | 100% | 6223.23 | 180 / 180 | 100% | 244.73 | 430 / 430 |
brain | 100% | 14271.09 | 2641 / 2642 | 100% | 251.40 | 705 / 705 |
skin | 100% | 12894.85 | 1808 / 1809 | 100% | 226.50 | 472 / 472 |
bladder | 100% | 7613.14 | 21 / 21 | 100% | 230.00 | 503 / 504 |
uterus | 100% | 7843.98 | 170 / 170 | 100% | 300.60 | 458 / 459 |
intestine | 100% | 7397.79 | 965 / 966 | 100% | 203.47 | 526 / 527 |
adrenal gland | 100% | 6813.43 | 258 / 258 | 100% | 231.57 | 229 / 230 |
kidney | 100% | 7597.34 | 89 / 89 | 100% | 150.13 | 897 / 901 |
breast | 100% | 5823.69 | 458 / 459 | 100% | 229.52 | 1114 / 1118 |
prostate | 100% | 6272.10 | 244 / 245 | 100% | 154.96 | 500 / 502 |
thymus | 99% | 5067.64 | 647 / 653 | 100% | 149.80 | 604 / 605 |
stomach | 99% | 5217.13 | 354 / 359 | 100% | 190.67 | 286 / 286 |
lung | 98% | 6094.28 | 569 / 578 | 100% | 189.47 | 1155 / 1155 |
pancreas | 87% | 2673.76 | 286 / 328 | 99% | 192.65 | 177 / 178 |
liver | 77% | 3215.62 | 173 / 226 | 99% | 130.42 | 403 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 170.90 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 246.32 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 261.47 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 139.77 | 1 / 1 |
blood vessel | 100% | 8666.24 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 6264.09 | 1199 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 5032.78 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 90% | 3953.11 | 777 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 3077.25 | 652 / 929 | 0% | 0 | 0 / 0 |
muscle | 23% | 637.74 | 181 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0110027 | Biological process | negative regulation of DNA strand resection involved in replication fork processing |
GO_0044458 | Biological process | motile cilium assembly |
GO_0006974 | Biological process | DNA damage response |
GO_0035721 | Biological process | intraciliary retrograde transport |
GO_0045019 | Biological process | negative regulation of nitric oxide biosynthetic process |
GO_0042326 | Biological process | negative regulation of phosphorylation |
GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0021762 | Biological process | substantia nigra development |
GO_0006915 | Biological process | apoptotic process |
GO_0007286 | Biological process | spermatid development |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005874 | Cellular component | microtubule |
GO_0072686 | Cellular component | mitotic spindle |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005813 | Cellular component | centrosome |
GO_0000776 | Cellular component | kinetochore |
GO_0005868 | Cellular component | cytoplasmic dynein complex |
GO_0097542 | Cellular component | ciliary tip |
GO_0005929 | Cellular component | cilium |
GO_0005829 | Cellular component | cytosol |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0030286 | Cellular component | dynein complex |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0036487 | Molecular function | nitric-oxide synthase inhibitor activity |
GO_0060703 | Molecular function | deoxyribonuclease inhibitor activity |
GO_0045505 | Molecular function | dynein intermediate chain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DYNLL1 |
Protein name | Dynein light chain Dynein light chain LC8-type 1 Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (DLC8) (Dynein light chain LC8-type 1) (Protein inhibitor of neuronal nitric oxide synthase) (PIN) |
Synonyms | DLC1 HDLC1 DNCLC1 DNCL1 hCG_27767 |
Description | FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures.; FUNCTION: Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1. .; FUNCTION: Regulates apoptotic activities of BCL2L11 by sequestering it to microtubules. Upon apoptotic stimuli the BCL2L11-DYNLL1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters BCL2 thus neutralizing its antiapoptotic activity. .; FUNCTION: Binds and inhibits the catalytic activity of neuronal nitric oxide synthase/NOS1. . FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures. .; FUNCTION: Binds and inhibits the catalytic activity of neuronal nitric oxide synthase/NOS1. .; FUNCTION: Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1. .; FUNCTION: Regulates apoptotic activities of BCL2L11 by sequestering it to microtubules. Upon apoptotic stimuli the BCL2L11-DYNLL1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters BCL2 thus neutralizing its antiapoptotic activity. . FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures. .; FUNCTION: Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1. . FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures. .; FUNCTION: Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1. . |
Accessions | ENST00000392508.2 P63167 ENST00000392509.6 ENST00000550178.1 ENST00000548342.5 ENST00000549989.1 ENST00000548214.1 ENST00000550845.5 ENST00000552870.1 F8VXI7 F8VRV5 ENST00000549649.5 ENST00000242577.11 F8VXL2 Q6FGH9 |